TY  - GEN
AU  - Weiss,Jared
AU  - Gilbert,Jill
AU  - Deal,Allison Mary
AU  - Weissler,Mark
AU  - Hilliard,Chris
AU  - Chera,Bhishamjit
AU  - Murphy,Barbara
AU  - Hackman,Trevor
AU  - Liao,Jay Justin
AU  - Grilley Olson,Juneko
AU  - Hayes,David Neil
TI  - Induction chemotherapy with carboplatin, nab-paclitaxel and cetuximab for at least N2b nodal status or surgically unresectable squamous cell carcinoma of the head and neck
SN  - 1879-0593
PY  - 2019///1115
KW  - Adult
KW  - Aged
KW  - Albumins
KW  - administration & dosage
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - adverse effects
KW  - Carboplatin
KW  - Cetuximab
KW  - Chemoradiotherapy
KW  - Cisplatin
KW  - Combined Modality Therapy
KW  - Drug Eruptions
KW  - etiology
KW  - Female
KW  - Head and Neck Neoplasms
KW  - drug therapy
KW  - Humans
KW  - Induction Chemotherapy
KW  - Kaplan-Meier Estimate
KW  - Male
KW  - Middle Aged
KW  - Neoadjuvant Therapy
KW  - Neoplasm Staging
KW  - Neutropenia
KW  - chemically induced
KW  - Paclitaxel
KW  - Progression-Free Survival
KW  - Radiotherapy, Intensity-Modulated
KW  - Squamous Cell Carcinoma of Head and Neck
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/j.oraloncology.2018.06.028
ER  -